Two epidemics, one patient: coinfection by SARS-CoV-2 and influenza in Colombia
DOI:
https://doi.org/10.15649/cuidarte.4264Keywords:
COVID-19, Influenza, Coinfection, Aortic Valve Insufficiency, Cardiac Prosthesis Implantation, MortalityAbstract
Highlights
- Coinfection with SARS-CoV-2 and the influenza virus (Flurona) is uncommon.
- Diagnosis is complex due to the similarity in the clinical manifestations of both diseases; therefore, microbiological and imaging tests play a fundamental role.
- Treatment represents a challenge, as the use of oseltamivir and dexamethasone in these patients remains controversial.
- A multidisciplinary approach to patients with Flurona is imperative to optimize clinical outcomes.
Introduction: Coinfection by SARS-CoV-2 and influenza (commonly referred to as "Flurona") presents a significant diagnostic and therapeutic challenge in pandemic and postpandemic settings. Although the two viruses share clinical similarities and transmission routes, their treatments differ substantially. The early suspicion of viral coinfection is crucial, particularly in patients with comorbidities or atypical clinical courses. A literature review was conducted in PubMed, Scopus, and Google Scholar (Spanish and English), identifying few documented clinical reports in Colombia. Case Description: We report the case of an 83-year-old male patient with a significant cardiovascular history, admitted to the intensive care unit for congestive heart failure and severe aortic valve disease. During hospitalization, the patient developed respiratory failure, and coinfection with influenza and SARS-CoV-2 was confirmed. Treatment included oseltamivir, oxygen therapy, and therapeutic thoracentesis. Transcatheter aortic valve implantation was indicated, but the patient died during the procedure. Conclusion: Coinfection by SARS-CoV-2 and influenza should be considered in the differential diagnosis of patients with acute respiratory distress, particularly in contexts of concurrent viral circulation. Prompt recognition enables targeted therapeutic intervention. A multidisciplinary approach is essential to optimize the prognosis in patients with complex comorbidities.
How to cite this article: Quintana-Ospina Jhon H, Osorio-Toro Luis M, Urriago-Osorio Gustavo A, Posu-Barco Jasbleidy, Rivas-Tafurt Giovanna P, Daza-Arana Jorge E, Oñate-Gutiérrez José M. Two epidemics, one patient: coinfection by SARS-CoV-2 and influenza in Colombia. Revista Cuidarte. 2025;16(3):e4264. https://doi.org/10.15649/cuidarte.4264
References
Balla M, Merugu GP, Patel M, Koduri NM, Gayam V, Adapa S, et al. COVID-19, Modern Pandemic: A Systematic Review From Front-Line Health Care Providers’ Perspective. J Clin Med Res. 2020;12(4):215. https://doi.org/10.14740/jocmr4142
Talbot HK, Martin ET, Gaglani M, Middleton DB, Ghamande S, Silveira FP, et al. Coronavirus disease 2019 (COVID-19) Versus Influenza in Hospitalized Adult Patients in the United States: Differences in Demographic and Severity Indicators. Clin Infect Dis. 2021;73(12):2240–7. https://doi.org/10.1093/cid/ciab123
Suescún-Carrero SH, Valdivieso-Bohórquez SJ, Ávila-Panche S, Ucros-Álvarez A, Rolon-Rojas MJ. Coinfección por SARS-CoV-2 con otros virus en pacientes de instituciones de salud del departamento de Boyacá, 2021-2022. Salud UIS. 2024;56:e24041. https://doi.org/10.18273/saluduis.56.e:24041
Dadashi M, Khaleghnejad S, Abedi Elkhichi P, Goudarzi M, Goudarzi H, Taghavi A, et al. COVID-19 and Influenza Co-infection: A Systematic Review and Meta-Analysis. Front Med (Lausanne). 2021;8. https://doi.org/10.3389/fmed.2021.681469
Quintana-Ospina JH, Osorio-Toro LM, Urriago-Osorio GA, Posu-Barco J, Rivas-Tafurt GP, Daza-Arana JE, et al. Double Challenge: COVID-19 meets the Influenza – First case report in Colombia. Mendeley Data. 2024;V1. https://doi.org/10.17632/2mfz5bxbh6.1
Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020;81(2):266–75. https://doi.org/10.1016/j.jinf.2020.05.046
Dadashi M, Khaleghnejad S, Abedi Elkhichi P, Goudarzi M, Goudarzi H, Taghavi A, et al. COVID-19 and Influenza Co-infection: A Systematic Review and Meta-Analysis. Front Med (Lausanne). 2021;8:681469. https://doi.org/10.3389/fmed.2021.681469
Carcamo Molina LM, Tejeda-Camargo MJ, Castro Clavijo JA, Montoya LM, Barrezueta-Solano LJ, Cardona-Montoya S, et al. Características clínicas y sociodemográficas de pacientes fallecidos por COVID-19 en Colombia. Revista Repertorio de Medicina y Cirugía. 2020:45–51. https://doi.org/10.31260/repertmedcir.01217372.1077
Orozco-Hernández JP, Montoya-Martínez JJ, Pacheco-Gallego MC, Céspedes-Roncancio M, Porras-Hurtado GL. Coinfección por SARS-CoV-2 y rinovirus-enterovirus en una paciente adulta joven críticamente enferma en Colombia. Biomédica. 2020;40(2):34–43. https://doi.org/10.7705/biomedica.5516
Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. J Adv Res. 2020;24:91–8. https://doi.org/10.1016/j.jare.2020.03.005
Manta B, Sarkisian AG, García-Fontana B, Pereira-Prado V. Fisiopatología de la enfermedad COVID-19. Odontoestomatologia. 2022;24(39). https://doi.org/10.22592/ode2022n39e312
Dueñas D, Daza J, Liscano Y. Coinfections and Superinfections Associated with COVID-19 in Colombia: A Narrative Review. Medicina (Kaunas). 2023;59(7):1336. https://doi.org/10.3390/medicina59071336
Kim D, Quinn J, Pinsky B, Shah NH, Brown I. Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens. JAMA. 2020;323(20):2085. https://doi.org/10.1001/jama.2020.6266
Ding Q, Lu P, Fan Y, Xia Y, Liu M. The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China. J Med Virol. 2020;92(9):1549–55. https://doi.org/10.1002/jmv.25781
Khodamoradi Z, Moghadami M, Lotfi M. Co-infection of Coronavirus Disease 2019 and Influenza A: A Report from Iran. Arch Iran Med. 2020;23(4):239–43. https://doi.org/10.34172/aim.2020.04
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–13. https://doi.org/10.1016/S0140-6736(20)30211-7
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061. https://doi.org/10.1001/jama.2020.1585
Sullivan SJ, Jacobson RM, Dowdle WR, Poland GA. 2009 H1N1 influenza. Mayo Clin Proc. 2010;85(1):64–76. https://doi.org/10.4065/mcp.2009.0588
Lamers MM, Haagmans BL. SARS-CoV-2 pathogenesis. Nat Rev Microbiol. 2022;20:270–284. https://doi.org/10.1038/s41579-022-00713-0
Martínez Chamorro E, Díez Tascón A, Ibáñez Sanz L, Ossaba Vélez S, Borruel Nacenta S. Diagnóstico radiológico del paciente con COVID-19. Radiologia. 2021;63(1):56. https://doi.org/10.1016/j.rx.2020.11.001
Organización Mundial de la Salud. Influenza (seasonal) [Internet]. Ginebra: OMS; 2021. Consulta: Julio 03, 2024. Disponible en: https://www.who.int/health-topics/influenza-seasonal
Krammer F, Smith GJD, Fouchier RAM, Peiris M, Kedzierska K, Doherty PC, et al. Influenza. Nature Reviews Disease Primers. 2018;3(4):1–21. https://doi.org/10.1038/s41572-018-0002-y
Kalil AC, Thomas PG. Influenza virus-related critical illness: pathophysiology and epidemiology. Crit Care. 2019;23(1):258. https://doi.org/10.1186/s13054-019-2539-x
Chotpitayasunondh T, Fischer TK, Heraud JM, Hurt AC, Monto AS, Osterhaus A, et al. Influenza and COVID-19: What does co-existence mean? Influenza Other Respir Viruses. 2021;15(3):407–12. https://doi.org/10.1111/irv.12824
O’Sullivan S, Torres A, Rodriguez A, Martin-Loeches I. Influenza management with new therapies. Curr Opin Pulm Med. 2020;26(3):215–21. https://doi.org/10.1097/MCP.0000000000000667
Mancilla-Galindo J, García-Méndez JÓ, Márquez-Sánchez J, Reyes-Casarrubias RE, Aguirre-Aguilar E, Rocha-González HI, et al. All-cause mortality among patients treated with repurposed antivirals and antibiotics for COVID-19 in Mexico City: A real-world observational study. EXCLI J. 2021;20:199. https://doi.org/10.17179/excli2021-3413
Díaz-Castrillón CE, Cortés N, Rey S, Pineda M, Díaz-Castrillón JF, Sierra S. Percepción de la pandemia COVID-19 en los servicios de cirugía en Colombia. Revista Colombiana de Cirugía. 2020;35(2):290–301. https://www.redalyc.org/articulo.oa?id=355563193021
Gupta AK, Leslie A, Hewitt JN, Kovoor JG, Ovenden CD, Edwards S, et al. Cardiac surgery on patients with COVID-19: a systematic review and meta-analysis. ANZ J Surg. 2022;92(5):1007–14. https://doi.org/10.1111/ans.17667
Creswell JW. Research Design: Qualitative, Quantitative, and Mixed Methods Approaches. 3rd ed. SAGE Publications; 2012.
Downloads
Published
How to Cite
Downloads
Issue
Section
Categories
License
Copyright (c) 2025 Revista Cuidarte
This work is licensed under a Creative Commons Attribution 4.0 International License.
Journal Cuidarte, scientific publication of open access, is licensed under a Creative Commons Attribution (CC BY-NC), which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Any other form of use such as reproduction, transformation, public communication or distribution, for profit, requires the prior authorization of the University of Santander UDES.
The names and e-mail addresses entered in the Journal Cuidarte will be used exclusively for the purposes stated by this magazine and will not be available for any other purpose or other person.
The articles published in the Journal Cuidarte represent the criteria of their authors and do not necessarily constitute the official opinion of the University of Santander UDES.
